(Q37697055)
Statements
Epirubicin in the treatment of malignant mesothelioma: a phase II cooperative study. The North-Eastern Italian Oncology Group (GOCCNE)--Mesothelioma Committee (English)
M D Magri
A Veronesi
S Foladore
D De Giovanni
C Serra
F Crismancich
G Tuveri
M Nicotra
M Tommasi